Welcome to SPP2395
SPP2395 is a collaboratively supported priority programme on microglia research.
With more than 30 principal investigators in two funding periods, we are driving
36 innovative projects across
more than 20 research institutes in Germany, Israel, the United Kingdom, Switzerland and Finland.
Together, we advance rigorous, transparent science to deepen our understanding of microglia in health and disease.
Our Mission
Microglia are the resident macrophages of the CNS, coordinating homeostatic regulation and mounting first-line immune responses. After two decades revealing their heterogeneity, the field is moving beyond simple “homeostatic” versus “disease-associated” labels toward context-aware biology in intact tissue. SPP2395 prioritizes in vivo investigation and the translation of preclinical insights using human post-mortem tissue, humanized mouse models, iPSC-derived human microglia, and patient data.
News
German Society of Neuroimmunology.
09.09.2025. German Society of Neuroimmunology (Deutsche Gesellschaft für Neuroimmunologie - DGNIM) will soon be established. For more information, please register here.
New Funding Period officially started.
08.09.2025. SPP2395 held its second kick-off meeting in Berlin on September 8–9, welcoming 12 new principal investigators to the consortium. Over two days, concise project updates, in-depth Q&A, and interactive sessions on microglia research and translational pipelines sparked lively discussion on shared resources, data standards, and reproducibility. The meeting strengthened collaboration across labs and set strong momentum for the next phase of SPP2395.
Recent Publications
-
-
-
Early Locus Coeruleus noradrenergic axon loss drives olfactory dysfunction in Alzheimer/’s disease
Participating Institutions
Berlin Institute of Health
Center for Molecular Neurobiology Hamburg
Charité Berlin
Christian-Albrechts-Universität zu Kiel
DZNE Bonn
DZNE München
Experimental Research in Stroke and Inflammation
Helmholtz-Zentrum für Infektionsforschung
Imperial College London
Institute for Stroke and Dementia Research
LMU Klinikum München
LMU München
Mannheim Institute for Innate Immunoscience
Max Delbrück Center Berlin
Medizinische Universität Wien
TU Braunschweig
TU München
Uniklinik Heidelberg
Universität zu Köln
Universitätsklinikum Bonn
Universitätsklinikum Freiburg
Universitätsklinikum Hamburg-Eppendorf
Universitätsklinikum Jena
Universitätsklinikum Leipzig
Universitätsklinikum Schleswig Holstein
Universitätsmedizin Göttingen
Universitätsmedizin Mainz
Université de Genève
University of Turku
Weizmann Institute of Science
SPP2395 PREMIER Wiki 










